MedPath

Which Apparatus for Inhaled Pentamidine?

Early Phase 1
Conditions
Healthy
Interventions
Drug: 500mg Amikacine (Amukin®) diluted in 4mL NaCl (0,9%)
Device: Respirgard II
Device: Isoneb®
Registration Number
NCT02277808
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Brief Summary

The reference nebulizer used for pentamidine nebulization is currently the Respirgard II ®, disposable pneumatic nebulizer. Other nebulizers are on the market and appear to have comparable properties and better availability to the hospital. Several studies remark that all nebulizers with comparable properties could be used for the nebulization.The aim of our work will be to evaluate and compare the pulmonary deposition between the reference nebulizer Respirgard II ®, and one of these nebulizers available on the market, the Isoneb ®. We will measure and compare these data's for each of the nebulizers via nebulization Amikacine and urinary dosage.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
10
Inclusion Criteria
  • Be in good health
Exclusion Criteria
  • Known Tachycardia
  • Renal Dysfunction
  • Respiratory Diseases and history

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Respirgard IIRespirgard IIDetermination of pulmonary deposition
Isoneb500mg Amikacine (Amukin®) diluted in 4mL NaCl (0,9%)Determination of pulmonary deposition
Respirgard II500mg Amikacine (Amukin®) diluted in 4mL NaCl (0,9%)Determination of pulmonary deposition
IsonebIsoneb®Determination of pulmonary deposition
Primary Outcome Measures
NameTimeMethod
Amikacine urinary dosage24 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinique universitaire Saint-Luc

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath